"Pharmaceutical Analytical,Studies Of AMAVATARI RASA and its Clinical efficacy in AMAVATA (Rheumatoid Arthritis)"

"Pharmaceutico Analytical studies OF Amavatari Rasa and its clinical evaluation w.s.r. to Amavata"

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/12/010976

Enrollment

Registered

2017-12-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Clinically diagnosed patients of Amavata(Rheumatoid Arthritis )as per criteria laid down by CCRAS

Interventions

Intervention1: Amavatari Rasa: Ayurvedic Herbo Mineral preparation used for Amavat(RA) Dose 125mg bid Composition: Parad,Gandhak,Amlaki,Haritaki,Vibhitak,Chitrak,Guggulu. Control Intervention1: Rasnad

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either sex with age between 18 to 60 years. 2.Patients present with classical signs and symptoms of Amavata. 3.Mild persistent cases of Rheumatoid Arthritis (as per ACR/EULAR classification criteria.)

Exclusion criteria

Exclusion criteria: 1.Patients with diseases like diabetes mellitus,tuberculosis,severe hypertension. 2.Patients with severe renal/hepatic diseases. 3.Pregnant/lactating mothers. 4.Patients on prolonged ( >6 weeks) medication with corticosteroids.

Design outcomes

Primary

Measure	Time frame
Improvement in patients condition and relief from symptoms.Timepoint: January 2018	—

Countries

India

Contacts

Public ContactDr Dharminder Kumar Sharma

National Institute of Ayurveda, Jaipur

parimisuresh.nia@gmail.com9214002003

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026